IP Library Granted Patent US 7,198,798
Granted Patent B2
US 7,198,798 · App. 10/142,658 · Granted Apr 3, 2007

Methods and devices for promoting endothelial morphogenesis

Assignee: University of Washington
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,198,798
App. No.
10/142,658
Granted
Apr 3, 2007
Kind
B2
Abstract

In one aspect the present invention provides methods for promoting endothelial morphogenesis. The methods of this aspect of the invention include the step of providing to one or more endothelial cells an amount of an osteoprotegerin sufficient to promote endothelial morphogenesis. The methods of this aspect of the invention can be practiced in vivo or in vitro. In another aspect, the present invention provides implantable medical devices that each include: (a) a device body; and (b) a layer attached to a surface of the device body, the layer comprising a molecule selected from the group consisting of osteoprotegerin and a nucleic acid molecule encoding osteoprotegerin, wherein the device is adapted to be completely or partially implanted into an animal body. The implanted medical device thus promotes the growth of blood vessels in the surrounding tissue, thereby reducing or preventing the formation of a collagenous capsule around the implanted medical device.

Claims (9)

1. A method for promoting endothelial morphogenesis, said method comprising the step of providing to one or more endothelial cells in vivo an amount of an osteoprotegerin sufficient to promote endothelial morphogenesis in tissue adjacent to an implanted medical device, wherein the osteoprotegerin is attached to a surface of the implanted medical device.

2. The method of claim 1 , wherein the osteoprotegerin is covalently attached to a surface of the medical device.

3. The method of claim 1 , wherein the osteoprotegerin is non-covalently attached to a surface of the medical device.

4. The method of claim 1 , wherein the osteoprotegerin is at least 70% identical to the osteoprotegerin consisting of the amino acid sequence set forth in SEQ ID NO: 2.

5. The method of claim 1 , wherein the endothelial morphogenesis is formation of capillaries.

6. The method of claim 5 , wherein the capillaries are formed in heart tissue.

7. The method of claim 1 , wherein the endothelial morphogenesis is formation of an endothelial lining in a blood vessel.

8. The method of claim 7 , wherein the endothelial lining is formed in an artificial blood vessel.

9. The method of claim 7 , wherein the endothelial lining is formed in a natural blood vessel.

Assignments (2)
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Sep 9, 2008
From: UNIVERSITY OF WASHINGTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021503/0270 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2004
From: MALYANKAR, URIEL M.; SCATENA, MARTA; GIACHELLI, CECILIA M.
To: UNIVERSITY OF WASHINGTON
Reel/Frame 015105/0859 →
Continuity (2)
Provisional Application 6029023000 · May 10, 2001
Related Publication 20030022834A1 · Jan 30, 2003